Sign Up to like & get
recommendations!
0
Published in 2020 at "Naunyn-Schmiedeberg's Archives of Pharmacology"
DOI: 10.1007/s00210-020-01873-7
Abstract: The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats. The effects of empagliflozin were compared with the standard medications for HF,…
read more here.
Keywords:
normoglycemic rats;
group;
heart failure;
empagliflozin ... See more keywords